Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Pharmaceutical Journal
1001-2494
2015 Issue 20
Overview on the Chinese Pharmacopoeia 2015 Editon
ZHANG Wei;LAN Fen;HONG Xiao-xu;Chinese Pharmacopeia Commission;
..............page:1743-1746
Current Situation and Trend in Pharmaceutical Microbial Control
HU Chang-qin;National Institutes for Food and Drug Control;
..............page:1747-1751
Standard Update and the Quality Control System of Traditional Chinese Medicines
SHI Shang-mei;Chinese Pharmacopoeia Commission;
..............page:1752-1753
Elementary Analysis of Quality Standards of Traditional Chinese Patent Medicines in the Chinese Pharmacopoeia 2015 Edition
ZHANG Li-qun;Hubei Institute for Food and Drug Control;
..............page:1754-1756
The Introduction on Chinese Pharmacopoeia 2015 Edition Volume Ⅱ
LI Hui-yi;JIANG Dian-zhuo;WANG Zhi-jun;ZHANG Xiao-hong;WANG Fei;ZHOU Yi;Chinese Pharmacopoeia Commission;
..............page:1757-1760
Revision of Specifications of Antibiotic in the Chinese Pharmacopoeia 2015 and the Trend of Antibiotic Quality Control
HU Chang-qin;National Institutes for Food and Drug Control;
..............page:1764-1769
General Introduction of the Revision in Chinese Pharmacopoeia 2015 Edition
GUO Zhong-ping;WANG Xiao-juan;CAO Yan;REN Yue-ming;HONG Xiao-xu;MA Rui;Chinese Pharmacopoeia Commission;
..............page:1773-1775
Introduction of the Related Content of Biotech Drugs Quality Control in the Chinese Pharmacopoeia 2015
RAO Chun-ming;WANG Jun-zhi;National Institutes for Food and Drug Control;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products;
..............page:1776-1781
Brief Introduction of Chinese Pharmacopoeia 2015 Edition Volume Ⅳ
HONG Xiao-xu;XU Hua-yu;SHANG Yue;JIN Gui-min;Chinese Pharmacopoeia Commission;
..............page:1782-1786
Introduction of General Chapters of Chinese Pharmacopoeia 2015 Edition Going into the New Normal Developing
JIANG Xiong-ping;HONG Xiao-xu;Institute for Drug Control of PLA;Chineses Pharmacopoeia Commission;
..............page:1787-1789
Identification of the Related Substances in Etimicin Sulfate Detected Under the Condition of Chinese Pharmacopoeia 2010 by LC/MS~n with Propionic Acid Enhanced Electrospray Ionization
YUAN Yao-zuo;WU Yu-ning;ZHAO Wei;WANG Fang;SU Xiao-chun;TAN Li;ZHANG Mei;HU Chang-qing;Jiangsu Institute for Food and Drug Control;China Pharmaceutical University;Changzhou Fangyuan Pharmaceutical Co.Ltd.;National Institute for Control of Pharmaceutical and Biological Products;
..............page:1790-1796
Improved Liquid Chromatography Combined with Pulsed Electrochemical Detection for the Analysis of Etimicin Sulfate
WU Yu-ning;ZHAO Wei;ZHU Xiao-yue;YUAN Yao-zuo;ZHANG Mei;XU Han-mei;PAN Guang-wen;HU Chang-qin;Jiangsu Institute for Food and Drug Control;Department of Life Science and Technology;China Pharmaceutical University;Thermofisher Science and Technology Co.Ltd.;National Institute for Food and Drug Control;
..............page:1797-1802
Chemical Components of Flavonoids from Leaves of Zelkova serrata
SUN Chong-lu;TANG Xiao-lei;ZHOU Jing-feng;WU Hao;Zhejiang Pharmaceutical College;
..............page:1803-1805
Suppression Activity and Mechanism of Compound 1487B on TNF-α Expression
MA Ming;ZHANG Yang;GUO Lian-hong;BAI Li-ping;JIANG Rong;LI Yuan;Key Laboratory of Biotechnology of Antibitics;Ministry of Health;Institute of Medicinal Biotechnology;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:1806-1810
Hypolipidemic Effect and Mechanism of Polyphenols from Rubus suavissirnu S. Lee in Hyperlipidemic Rats
WANG Shuo;HOU Xiao-li;WEI Fan;ZHOU Xiao-lei;GONG Xiao-mei;MIAO Jian-hua;The National Engineering Laboratory of Southwest Endangered Medicinal Resources Development of Guangxi Medicinal Plant;
..............page:1811-1815
Preparation and Characterization of Hyaluronic Acid-Sinomenine Conjugate
LIU Jie;LI Da-wei;CAO Xin-ke;WANG Chang-bin;ZHANG Jian-qiang;CHEN Jian-ying;Key Laboratory of Biopharmaceuticals of Shandong Province;Shandong Academy of Pharmaceutical Sciences;Key Laboratory of Mucosal and Transdermal Drug Delivery Technology in Shandong Province;Shandong Freda Co.LTD;Key Laboratoryof Mucosal and Transdermal Drug Delivery Technology in Shandong Province;Shandong Freda Co.LTD;
..............page:1816-1821
HPLC-MS/MS Determination of Febuxostat in Human Plasma and Its Application to Pharmacokinetic Study
DENG Ke;XIE Hui-ru;WANG Ling;JIANG Xue-hua;West China School of Pharmacy;Sichuan University;
..............page:1822-1828
The Influence of Therapeutic Drug Monitoring Compliance on Efficiency and Safety about Valproic Acid in Epileptic Children
XU Shan-sen;ZHANG Ti;LIU Mei;ZHAO Li-mei;Department of Pharmacy;Shengjing Hospital of China Medical University;
..............page:1829-1832
Pharmaceutical Administration for Anti-Ebola Outbreak Mission of Chinese Military Medical Aid Team in Sierra Leone
XIA Hui;LIU Feng-qun;QIN Li;SUN Zhi-qiang;ZHAO Qing-guo;HAN Jing;DUAN Hui-juan;No.302 Hospital of PLA;
..............page:1833-1835
Perspectives on Development Direction of Hospital Pharmacy and Working Mode of Pharmacist Under the New Condition of Medical Reform
LIU Hong-ling;WANG Hui-ming;HE Hui-shan;FENG Xiao-jie;SUN Wei;The Affiliated Hospital of Qingdao University;
..............page:1836-1840